Amgen Stock News

Onyx Pharmaceuticals - Wikipedia, The Free Encyclopedia
Onyx Pharmaceuticals Inc. is a biopharmaceutical company headquartered in South San Francisco, Amgen announced it was acquiring Onyx in an agreed $10.4 billion deal. Other backers of Onyx were Avalon Ventures, sending the shares up by around 30% after the news was announced. ... Read Article

News Release - EDB
News Release One Amgen Center Drive-1799 Telephone 805-447-1000 www.Amgen.com AMGEN TO BUILD STATE-OF-THE-ART MANUFACTURING FACILITY IN SINGAPORE repurchase our common stock. CONTACT: Amgen, Thousand Oaks Ashleigh Koss, 805-313-6151 (media) ... Retrieve Document

Fac T She E T - Amgen
Fac t She e t Amgen Amgen is a leading human therapeutics company in the biotechnology Stock Listing Nasdaq: AMGN Chairman and CEO Kevin W. Sharer Med Ad News Amgen has been named among the top two most admired biotech ... Retrieve Content

Investor Information Investors
Home Mission MedAnywhere Technology Investors News Contact . Investor Information . Recent Successes Financial Reports LEVEL medical technology than . right now! What if you owned a part of the Amgen original stock offering - or had a stake in Plavix®, Lipitor® or Cialis® before they were ... Read Document

HEALTHCARE - Southern Methodist University
Investors are still suspicious of biotechnology investments as a result of bad news in recent months, including Chiron Corp.'s flu vaccine shortage, Amgen’s forecast for value of Amgen’s stock is $58.64 per share. The price deviation across the five models was merely $49m or 3 ... View Full Source

Biotech Stock Roundup: Vertex CF Drug Approved, Biogen Strikes Deal For Gene Therapy - Analyst Blog
Biotech Stock Roundup: Vertex CF Drug Approved, Biogen Strikes Deal for Gene Therapy - Analyst Blog ... Read News

CooleyAlert!
CooleyAlert! www.cooley.com Key Attorney ContACts News from our Securities Litigation Group. www.cooley.com COOLEY ERT! FEBRU A RY 2013 2 nition do not affect a stock’s price, Amgen claimed there was no basis to presume reliance. ... Document Retrieval

Amgen - Wikipedia, The Free Encyclopedia
Amgen (formerly Applied Molecular Genetics) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Located in the Conejo Valley, Amgen is the world's largest independent biotechnology firm. ... Read Article

NOVEMBER 12, 2012 NEWS ANALYSIS SAN FERNANDO VALLEY BUSINESS ...
Once a growth stock, it just started paying dividends last year. They re at a stage now where they are high after positive news. Amgen Inc. Thousand Oaks CEO: Robert Bradway Employees: 17,500 Market Cap: $65.5 billion P/E: 15 EPS: $5.57 Source: Yahoo Finance ... Read Document

SEC NEWS DIGEST
SEC NEWS DIGEST Issue 2001-50 March 14, 2001 forth in a letter to the Nasdaq Stock Market, S-8 AMGEN INC, ONE AMGEN CENTER ORr TE, THOUSAND OAKS, CA 91320 (805) -44-7-10 - 5,000,000 ($360,925,000) COMMON STOCK. (FILE 333- ... Return Document

Co-Founder Dr. Joseph Rubinfeld To
November 6, 2012 Amarantus BioSciences Appoints Amgen Co-Founder Dr. Joseph Rubinfeld to Advisory Board SUNNYVALE, Calif., Nov. 6, 2012 /PRNewswire/ -- Amarantus BioSciences, Inc. ... Access Content

Astellas Announces Termination Of Amgen-sponsored Clinical ...
Astellas announces termination of Amgen-sponsored clinical studies of rilotumumab in gastric cancer . Tokyo, Our stock price may be affected by actual or perceived market opportunity, The scientific information discussed in this news release related to our product candidates is ... View Document

News Release - ExxonMobil
News Release. Exxon Mobil Corporation 5959 Las Colinas Boulevard Irving, TX 75039 Exxon Mobil Corporation purchased 63million shares of its common stock for the treasury at a gross cost billion. ... Get Content Here

Are PCSK9 Inhibitors The New Statins? - About.com Health
Statins are drugs such as Zocor and Crestor.) This optimism managed to spill over to the stock market, where Amgen's stock price increased by nearly 10 percent during the time that the ACC took place. ... Read Article

FOR IMMEDIATE RELEASE Contact: Villa International VILLA ...
ELIGBILE COMMON STOCKS FOR THE VILLA INTERNATIONAL ROLLS BACK DECLINING STOCK PRICES PROMOTION Company Symbol July 1, 2008 Closing Price ... Fetch Full Source

Amgen’s High Hopes For Vectibix & Denosumab
Visit the digital version of Physicians’ Financial News at Amgen’s shares have been fluctuating in response to this steady stream of news. common stock validly tendered and not validly withdrawn in the offer, ... Fetch Content

BIOTECH’S MOST RESPECTED NEWS SOURCE FOR MORE THAN 20 YEARS TM million from purchase of common stock by Amgen – 8.4 million shares at about $1 . 18 each. Amgen owns 7.3 percent of Cytokinetics, which also could collect pre-commercialization ... Retrieve Doc

(AMGN) Amgen, Inc. - YouTube
Rating is available when the video has been rented. (AMGN) Amgen, Inc ... View Video

SEC Complaint: GARY K. MELTON
Amgen's common stock trades on he NASDAQ Stock Market under the symbol "AMGN." 8. Abgenix was a Delaware corporation with its principal offices in purchase Abgenix stock to mean that more favorable news about Abgenix was forthcoming. 12. Melton knew, ... View Document

Amgen's Second Quarter 2009 Adjusted Earnings Per Share ...
The applicable periods, stock option expense, Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 Tuesday, 28 July 2009 Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A ... Retrieve Here

Amgen's Single Most Important FDA Decision Of 2015 Is Nearly Here
Amgen's Single Most Important FDA Decision of 2015 Is Nearly Here ... Read News

Model N Announces Date Of Third Quarter Fiscal 2015 Financial Results
Model N, Inc. , the leader in Revenue Management Cloud solutions to the life science and technology industries, plans to announce financial results for the third quarter fiscal 2015 after market close on Monday, August 10, 2015. ... Read News

Eat Or Be Eaten: A Theory Of Mergers And Firm Size;
News: The Boston Globe – Massachusetts, June 16, 1999, and “Takeover Rumors Fuel Another Rise in Amgen Stock…”, The Los Angeles Times, August 30, 1994). 4 Eat or Be Eaten: A Theory of Mergers and Firm Size WP-06-14 Gary Gorton, Matthias Kahl, and Richard Rosen . ... Doc Viewer

Amgen Elects Option On Cardiac Drug, Improving Cytokinetics ...
May 26, 2009 Number 001 Amgen Elects Option On Cardiac Drug, Improving Cytokinetics' Strong Cash Position Only a week after bringing in $14 million from a registered direct offering of stock, Cytokinetics grew even wealthier on ... Read Content

Q2 2012 - Multi Cap Equity - Westport Resources
During the second quarter we replaced Amgen with Agrium. Amgen stock had a major recovery in recent quarters and we were able to get out with a small loss (i.e. about 10%). Agrium is an Q2 2012 - Multi Cap Equity Author: Kristin Andree ... View Doc

11 Stem Cell stocks - Wall Street News Network
Amgen AMGN China Cord Blood Corporation CO ARIA CELG CYTX DNDN GERN IART CUR OSIR STEM International Stem Cell Corporation StemCells Inc. Alexion Pharmaceuticals ARIAD Pharmaceuticals Cellgene Cytori Therapeutics, Inc. Dendreon Corporation Geron Integra Lifesciences Holdings ... Fetch Document

Amgen Purchases KAI Pharmaceuticals (AMGN) - YouTube
Amgen (NASDAQ:AMGN) announced plans to purchase KAI Pharmaceuticals. KAI's main product, KAI-4169 is currently in its mid-stage development for treatment of ... View Video

Biotech Stocks Outlook Searching For The Next Amgen And Why ...
Biotech Stocks Outlook Searching for the Next Amgen and Why Biotechs Are Back To Stay even a small investment in this stock is going to be an absolute home run. editors and consultants of Angel Publishing may actively trade in the investments discussed in this news- ... Document Retrieval